UTI AMC’s (UTI) Q3FY23 performance is on track to achieve Rs5bn/5.6bn EBITDA ex other income in FY23/24E. Our thesis of employee cost rationalisation and better-than- peer growth driven by diversification (20% total revenue from non-MF businesses) remains valid.